Literature DB >> 18689907

Clinical course and prognostic factors of clinical early IgA nephropathy.

P Shen1, L He, D Huang.   

Abstract

BACKGROUND: Immunoglobulin A nephropathy (IgAN) is prevalent in many countries including China. At the time of diagnosis many IgAN patients present with normal renal function, proteinuria of 0.4 g/d or less, and normal blood pressure and they are classified as clinically early IgAN patients. However, the natural history of clinically early IgAN and prognostic factors has not yet been clarified.
METHODS: We investigated 177 early IgAN patients (108 males and 69 females) followed up for a mean period of 111 +/- 43 months.
RESULTS: During the follow-up period among 177 clinically early IgAN patients, urinary abnormalities disappeared in 9% of the patients; increased proteinuria was present in 79 patients (46%). The prevalence of hypertension was 38% (68 patients), and 24% (43 patients) developed renal insufficiency. Poor renal outcome was associated with haematuria, urinary protein excretion index (UPEI, the product of urinary protein excretion at the time of renal biopsy and prebiopsy duration), and tubulointerstitial lesions.
CONCLUSION: Renal outcome is dismal in patients with clinically early IgAN. Haematuria, UPEI, and tubulointerstitial lesions could be useful markers of a progressive course.

Entities:  

Mesh:

Year:  2008        PMID: 18689907

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  17 in total

Review 1.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

2.  Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.

Authors:  Kayu Tanaka; Takahito Moriyama; Chihiro Iwasaki; Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2014-12-05       Impact factor: 2.801

Review 3.  [Pathophysiology and treatment of IgA nephropathy].

Authors:  R Bollin; H Haller
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

4.  Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy.

Authors:  Akifumi Yamada; Shuichiro Fujinaga; Koji Sakuraya; Asanuma Satoshi; Daishi Hirano
Journal:  Clin Exp Nephrol       Date:  2018-03-08       Impact factor: 2.801

5.  Characteristics of IgA nephropathy in advanced-age patients.

Authors:  Yasuko Oshima; Takahito Moriyama; Mitsuyo Itabashi; Takashi Takei; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2014-11-12       Impact factor: 2.370

6.  The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching.

Authors:  Mijia Liu; Xueyan Bian; Li Wang; Guisen Li
Journal:  Front Med (Lausanne)       Date:  2022-07-06

7.  Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.

Authors:  Eduardo Gutiérrez; Isabel Zamora; José Antonio Ballarín; Yolanda Arce; Sara Jiménez; Carlos Quereda; Teresa Olea; Jorge Martínez-Ara; Alfons Segarra; Carmen Bernis; Asunción García; Marian Goicoechea; Soledad García de Vinuesa; Jorge Rojas-Rivera; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

8.  Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria.

Authors:  Qing Jia; Feng Ma; Xiaoxia Yang; Linlin Li; Chunmei Liu; Ruiling Sun; Rong Li; Shiren Sun
Journal:  Clin Exp Nephrol       Date:  2021-11-01       Impact factor: 2.801

9.  Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.

Authors:  Zhijuan Kang; Zhihui Li; Cuirong Duan; Tianhui Wu; Mai Xun; Yunfeng Ding; Yi Zhang; Liang Zhang; Yan Yin
Journal:  Pediatr Nephrol       Date:  2015-03-15       Impact factor: 3.714

10.  Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.

Authors:  Yong-Chul Kim; Ho Jun Chin; Ho Suk Koo; Suhnggwon Kim
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.